These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8098779)

  • 1. Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes.
    Baldick CJ; Moss B
    J Virol; 1993 Jun; 67(6):3515-27. PubMed ID: 8098779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters.
    Baldick CJ; Keck JG; Moss B
    J Virol; 1992 Aug; 66(8):4710-9. PubMed ID: 1629951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.
    Zhang Y; Keck JG; Moss B
    J Virol; 1992 Nov; 66(11):6470-9. PubMed ID: 1404599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene.
    Passarelli AL; Kovacs GR; Moss B
    J Virol; 1996 Jul; 70(7):4444-50. PubMed ID: 8676468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L gene.
    Keck JG; Kovacs GR; Moss B
    J Virol; 1993 Oct; 67(10):5740-8. PubMed ID: 8371339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
    Ramsey-Ewing A; Moss B
    Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A2L intermediate gene product is required for in vitro transcription from a vaccinia virus late promoter.
    Hubbs AE; Wright CF
    J Virol; 1996 Jan; 70(1):327-31. PubMed ID: 8523544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of vaccinia virus late promoters.
    Davison AJ; Moss B
    J Mol Biol; 1989 Dec; 210(4):771-84. PubMed ID: 2515287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus directs the synthesis of early mRNAs containing 5' poly(A) sequences.
    Ink BS; Pickup DJ
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1536-40. PubMed ID: 1968253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of vaccinia virus early promoters.
    Davison AJ; Moss B
    J Mol Biol; 1989 Dec; 210(4):749-69. PubMed ID: 2515286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the vaccinia virus gene encoding an 18-kilodalton subunit of RNA polymerase and demonstration of a 5' poly(A) leader on its early transcript.
    Ahn BY; Jones EV; Moss B
    J Virol; 1990 Jun; 64(6):3019-24. PubMed ID: 2335825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a temperature-sensitive mutant of vaccinia virus defective in late but not intermediate gene expression.
    Carpenter MS; DeLange AM
    Virology; 1992 May; 188(1):233-44. PubMed ID: 1566576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-acting sequences affecting the length of the poly(A) head of vaccinia virus late transcripts.
    de Magistris L; Stunnenberg HG
    Nucleic Acids Res; 1988 Apr; 16(8):3141-56. PubMed ID: 2897657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription initiation factor activity of vaccinia virus capping enzyme is independent of mRNA guanylylation.
    Harris N; Rosales R; Moss B
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2860-4. PubMed ID: 8385346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus serpin-1 deletion mutant exhibits a host range defect characterized by low levels of intermediate and late mRNAs.
    Shisler JL; Isaacs SN; Moss B
    Virology; 1999 Sep; 262(2):298-311. PubMed ID: 10502509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5' noncoding region sequence of the Choristoneura biennis entomopoxvirus spheroidin gene functions as an efficient late promoter in the mammalian vaccinia expression system.
    Pearson A; Richardson C; Yuen L
    Virology; 1991 Feb; 180(2):561-6. PubMed ID: 1899170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of transcription from a vaccinia virus early promoter late in infection.
    Garcés J; Masternak K; Kunz B; Wittek R
    J Virol; 1993 Sep; 67(9):5394-401. PubMed ID: 8350402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine N1-oxide inhibits vaccinia virus replication by blocking translation of viral early mRNAs.
    Kane EM; Shuman S
    J Virol; 1995 Oct; 69(10):6352-8. PubMed ID: 7666536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence.
    Wright CF; Moss B
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8883-7. PubMed ID: 2827158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of vaccinia virus promoter activity in fowlpox and vaccinia virus recombinants.
    Prideaux CT; Kumar S; Boyle DB
    Virus Res; 1990 Apr; 16(1):43-57. PubMed ID: 2161593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.